Drug profile

The FDA adverse-event record for Cough Tablets

72 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Cough Tablets. See the species affected, top reactions, and outcomes below.

72
adverse-event reports
13.9%
death-coded share
Dog
most-reported species
13
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
72
Total Reports
10
Deaths Reported
13.9%
Death Rate

Active Ingredients

Cough Tablets

Administration Routes

OralUnknown

Species Affected

Dog 72

Most Affected Breeds

Spitz - German Pomeranian 7
Beagle 7
Chihuahua 7
Boxer (German Boxer) 6
Maltese 6
Shepherd Dog - Australian 5
Retriever - Labrador 4
Retriever - Golden 3
Poodle - Toy 2
Terrier - Yorkshire 2

Most Reported Reactions

Vomiting 13
Cough 12
Lethargy (see also Central nervous system depression in 'Neurological') 12
Lack of efficacy - NOS 10
Other abnormal test result NOS 9
Seizure NOS 9
Abnormal radiograph finding 8
Elevated serum alkaline phosphatase (SAP) 7
Elevated alanine aminotransferase (ALT) 6
Diarrhoea 6
Death 6
Facial swelling (see also 'Skin') 5

Outcome Breakdown

Ongoing
36 (50.0%)
Outcome Unknown
13 (18.1%)
Recovered/Normal
13 (18.1%)
Died
6 (8.3%)
Euthanized
4 (5.6%)

Cough Tablets Adverse Event Insights

72 reports name Cough Tablets; 10 recorded a death outcome (13.9% of reported events, not a population-level mortality rate). Active ingredient: Cough Tablets. Administration routes: Oral, Unknown.

By species: Dog (72 reports). By breed: Spitz - German Pomeranian (7), Beagle (7), Chihuahua (7).

Leading clinical signs: Vomiting (13), Cough (12), Lethargy (see also Central nervous system depression in 'Neurological') (12), Lack of efficacy - NOS (10). Outcome, 72 coded reports: Ongoing leads at 50.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.